glp-1 usage receptor agonists show promise in treating substance use disorders The Multi-Sector Impacts of GLP-1RA
Description
Now it has been shown that limited experimental data can be used to train sophisticated machine learning models to accurately predict the activity of previously uncharacterized peptide ligand variants.

Cutting-edge weight-loss drugs like Wegovy and Ozempic can help treat alcoholism, a new study says.

These ingredients help convert carbohydrates, proteins, and fats into usable energy to combat fatigue and stay active throughout the day
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
Background Glucagon-like peptide-1 receptor agonists (GLP-1RA) have cardiovascular benefits in type 2 diabetes, but none of the cardiovascular trials studied atrial fibrillation/atrial flutter (AF) as a primary endpoint

Quick, confidential assessment
Pathological impulsivity is encountered in a broad range of psychiatric conditions and is thought to be a risk factor for aggression directed against oneself...
